01
Dual pathway interest
GIP plus GLP-1 is the scientific reason this molecule is in so many conversations. Interest is not a result.
- ·Satiety and metabolic signaling in the literature
- ·No promised outcome
- ·Side-effect counseling in the visit
RE GEN RX · peptides / Tirzepatide
A dual GIP/GLP-1 protocol when a licensed Illinois clinician confirms the plan.
Oswego, Illinois · 74 W. Washington St · serving the Fox Valley. A licensed Illinois clinician still decides. Compounded medications are not FDA-approved.
Legal status reviewed July 2026 · Weekly · clinician-titrated
What is Tirzepatide?
Tirzepatide acts on GIP and GLP-1 receptors. Brand-name products are FDA-approved for specific indications. A compounded request is not those products. RE GEN treats it as a clinician-directed protocol with a lawful compounding conversation — or we do not send it.
How people usually take it. Weekly injection when prescribed. Monthly requests are a starting conversation, not a locked dose.
Interest is not a result. We keep the research language and skip the miracle.
01
GIP plus GLP-1 is the scientific reason this molecule is in so many conversations. Interest is not a result.
02
We will not imply that a compounded vial is the approved brand. That distinction is part of informed consent.
03
Pick a monthly request if you already have a preference. The licensed Illinois clinician confirms or changes the plan.
A note on honesty: we will tell you what the literature supports and what it does not. Animal data is not a human guarantee. Anecdotes are not trials.
Incretin biology has a substantial preclinical base.
Brand-name tirzepatide has large human programs. Compounded tirzepatide does not wear that label.
Legal basis at RE GEN · July 2026
Available to request when a licensed Illinois clinician decides it is appropriate. Compounded medications are not FDA-approved finished drugs.
A licensed Illinois clinician still decides.
From-prices plus shipping. A licensed Illinois clinician still decides. If they prescribe, you pay this invoice. If they don't, we refund.
from $100
Request this protocol →Peptide education for Illinois patients at RE GEN in Oswego — not a substitute for a visit.
A dual GIP/GLP-1 receptor agonist. Brand-name products exist for labeled uses. Compounded tirzepatide is requested only after a clinician decision and a lawful compounding basis.
Compounded tirzepatide is not an FDA-approved finished drug. When RE GEN can request it, it is because a documented §503A basis exists for that bulk substance or an approved-drug component — and a licensed Illinois clinician still has to decide it is appropriate for you.
Start a visit. We serve Illinois patients from 74 W. Washington St in Oswego. A licensed Illinois clinician reviews history and goals. If they prescribe, a licensed 503A pharmacy compounds it and it ships. If they do not prescribe, we refund the therapy charge.
Published starting points differ by program and vial math. The visit confirms what is actually prescribed. Shipping is separate.
No. Educational pages explain why people ask and what the research landscape looks like. Individual response varies. Compounded medications are not FDA-approved, and a request is not a guaranteed prescription.
Illinois practice · licensed 503A compounding
Hello Gorgeous PC · 74 W. Washington St, Oswego, IL
RE GEN desk 630-636-6193
Start a visit, a licensed Illinois clinician reviews, then you pay the invoice. If they don't prescribe, we refund.